Clinical Trial Update: Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports completion of a study evaluating Enbrel (etanercept) in patients with rheumatoid arthritis and comorbid disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED